With some viruses, once you have been infected and have developed antibodies, you will be immune to that virus for life. Past infection with the SARS-CoV-2 virus, which causes COVID-19, does not, as far as is known at this ...
Dec 16, 2020
0
3
The U.K. has become the first country to approve the Pfizer/BioNTech vaccine for widespread use. The government has ordered 40 million doses and the first batch of 800,000 doses is expected to be shipped from Belgium – ...
Dec 2, 2020
0
12
Newly released research suggests that levels of antibodies against the coronavirus have declined across the UK population since testing began. Having randomly sampled 365,000 people across the country, the React2 study—which ...
Oct 28, 2020
0
1
WEHI researchers have used powerful 'single cell multi-omics' technologies to discover a previously unknown ancestor of T and B lymphocytes, which are critical components of our immune system.
Oct 19, 2020
0
17
A recent study led by the University of Nebraska–Lincoln has implicated a leading suspect in two open medical cases: the common recurrence of multiple sclerosis and the fuzzy thread tying MS to mononucleosis.
Jul 6, 2020
0
240
Whenever a germ gets into the human body, the immune system usually responds immediately to fight off the enemy attacker. One of our defense system's most important strategies involves B lymphocytes, also known as B cells, ...
Jul 1, 2020
0
8
The engineering of specific virus-targeting receptors onto a patient's own immune cells is now being explored by scientists from Duke-NUS Medical School (Duke-NUS), as a potential therapy for controlling infectious diseases, ...
Apr 21, 2020
0
182
Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases in Vienna, the University Medical Center of Regensburg, ...
Jan 29, 2020
0
3
Researchers of Sechenov University, together with colleagues from Russia and Austria, have summarized everything known about cells producing group E antibodies. These molecules are responsible for most of the allergic reactions, ...
Nov 26, 2019
0
3
Henry Ford Cancer Institute has treated its first patient with CAR T-cell therapy, an approach that uses engineered cells from a patient's immune system to destroy cancer. The altered cells remain active for years after the ...
Jun 18, 2019
0
3
